Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)

SHE:002332 Revenue

Zhejiang Xianju Pharmaceutical had revenue of 969.74M CNY in the quarter ending September 30, 2026, with 1.40% growth. This brings the company's total for the last twelve months to 3.86B, up 7.59% year-over-year. In the year 2025, Zhejiang Xianju Pharmaceutical had annual revenue of 3.76B, down -6.04%. That makes Zhejiang Xianju Pharmaceutical the 10,404th largest company in the world by revenue and 1,698th in China.

• Revenue (ttm): 3.86B
• Revenue Growth: +7.59%
• P/S Ratio: 2.23
• Revenue / Employee: 1.20M
• Employees: 3,209
• Market Cap: 8.60B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 2.69B 71.6%
• Overseas 1.07B 28.4%

Fiscal year ended Dec 31, 2025 See the full SHE:002332 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.76B	-241.72M	-6.04%
Dec 31, 2024	4.00B	-122.73M	-2.98%
Dec 31, 2023	4.12B	-256.41M	-5.85%
Jan 1, 2023	4.38B	22.48M	0.52%
Jan 1, 2022	4.36B	338.47M	8.42%

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error